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© 2011 The Japan Society of Histochemistry and Cy- Heat shock protein 47 (HSP47) is a collagen-specific molecular chaperone that helps the
molecular maturation of various types of collagens. A close association between increased
expression of HSP47 and the excessive accumulation of collagens is found in various
human and experimental fibrotic diseases. Increased levels of HSP47 in fibrotic diseases
are thought to assist in the increased assembly of procollagen, and thereby contribute to the
excessive deposition of collagens in fibrotic areas. Currently, there is not a good universal
histological marker to identify collagen-producing cells. Identifying phenotypically altered
collagen-producing cells is essential for the development of cell-based therapies to reduce
the progression of fibrotic diseases. Since HSP47 has a single substrate, which is collagen,
the HSP47 cellular expression provides a novel universal biomarker to identify phenotypi-
cally altered collagen-producing cells during wound healing and fibrosis. In this brief article,
we explained why HSP47 could be used as a universal marker for identifying phenotypically
altered collagen-producing cells.
Key words: HSP47, collagen, fibrosis, biomarker
I. Heat Shock Proteins
Heat shock proteins (HSPs) are a distinctive class of
proteins that play an important role in the assembly and
folding of intracellular polypeptides and help to restore the
biological activities of abnormal proteins. HSPs also assist
in the recovery of the cell from stress, either by refolding
damaged proteins or by degrading them, and provide a cellu-
lar defense against a wide range of stresses and injuries by
restoring protein homeostasis. Furthermore, these proteins
can play important roles in signal transduction by maintain-
ing and stabilizing intracellular microenvironments.
The heat shock response was first observed by Ritossa
in  Drosophila in 1962 [55] and is now widely accepted
to be a universally conserved cellular defense system. The
heat shock response is mediated by a group of HSPs; this
response has been observed in both eukaryotic and prokary-
otic cells. Some HSPs are strictly stress-inducible, whereas
others may be constitutively expressed or developmentally
regulated. A number of HSPs are constitutively expressed
and actively involved in maintaining cellular homeostasis by
acting as molecular chaperones [3, 6, 9]. HSPs regulate the
folding and assembly of nascent and unfolded peptides, help
in transporting proteins to a particular subcellular compart-
ments and assist in the degradation of misfolded proteins [8].
Both  in vivo and in vitro studies have documented
important roles of HSPs in the pathogenesis of various
diseases, ranging from autoimmune diseases (arthritis and
diabetes) to tumors and fibrotic diseases. In this article, we
will briefly explain how HSP47 can be used as a novel bio-
marker to identify phenotypically altered collagen-producing
cells during wound healing and fibrosis.Taguchi et al. 36
II. HSP47
HSP47 was first characterized by Kurkinen et al. in
murine parietal endoderm cells [13]. HSP47 is a stress-
inducible 47 kD collagen-binding glycoprotein that is
present in the endoplasmic reticulum of collagen-secreting
cells [21, 61]. HSP47 can transiently interact with procol-
lagen during its folding, assembly and transport from the
endoplasmic reticulum of mammalian cells. The collagen
binding ability of HSP47 has been demonstrated by co-
immunoprecipitation studies [26]. HSP47 can bind various
types of collagens (types I to V), as determined by in vitro
pull-down studies using surface plasmon resonance [22, 57].
Studies have suggested that HSP47 can potentially stabilize
the correctly folded collagen helix and prevent heat denatur-
ation before its transport from the endoplasmic reticulum
[64, 65]. The essential role of HSP47 in collagen synthesis
was further established in Hsp47 knockout mice, in which
the genetic inactivation of Hsp47 resulted in abnormal col-
lagen formation and impaired organogenesis. Knockout of
Hsp47 is embryonically lethal, and the mice usually die at
embryonic day 11.5 [57]. Interestingly, no collagen fibrils
are present in the mesenchyme-epithelial cell junctions of
Hsp47 disrupted mice [57]. Taken together, the data from
these in vitro and in vivo studies clearly suggest that HSP47
plays an important role during collagen production and may
also play a role in subsequent fibrogenesis [45, 58].
III. HSP47 in Fibrotic Diseases
The development of irreversible tissue fibrosis is a
relatively late change that occurs in most organs following
chronic inflammation. The excessive production of matrix
proteins by the activated and phenotypically altered resident
cells gradually leads to the development of organ fibrosis.
The increased expression and deposition of collagens (type
I, type III and type IV) were detected in various organ
fibroses in human diseases [40–42], a pattern that is similar
to the organ fibrosis observed in experimental models [5,
15, 72, 73]. Advanced stages of fibrosis compromise the
functionality of the involved tissues and lead to the develop-
ment of complications related to end-stage organ failure
[1, 12, 29, 38, 53, 61, 68, 69]. For instance, renal fibrosis can
alter the water, electrolyte and mineral ion balance, inducing
vascular calcification and skeletal mineralization defects
[27, 28, 30–33, 49]. Similarly, advanced lung and liver
fibrosis can lead to organ failure and increase the overall
mortality levels of affected patients [18, 68]. Irrespective
of organ involvement, a fibrogenic role of HSP47 is con-
sistently observed in fibrotic diseases.
Fig. 1. Alcoholic liver cirrhosis in a 56-year-old female patient showing severe fibrotic changes. Typical hepatic nodular lesions (upper panels)
are observed, as shown by both hematoxylin and eosin (HE) staining. Fatty changes in the liver with characteristic Mallory-bodies (arrows)
are shown in the lower panels. No such changes are noted in the control liver obtained during autopsy from a 59-year-old female patient of
progressive systemic sclerosis.HSP47 and Fibrosis 37
Increased glomerular expression of HSP47 has been
shown to be correlated with an increased accumulation
of collagens in scleroproliferative glomeruli in an anti-
thymocyte serum-induced experimental model of nephritis
[50]. Phenotypically altered collagen-producing glomeru-
lar myofibroblasts (alpha-smooth muscle actin-positive) and
glomerular epithelial cells (desmin-positive) are the main
HSP47-producing cells in the scleroproliferative glomeruli
[50]. Such glomerulosclerosis in an experimental model of
nephritis could be delayed by knocking down HSP47 in
vivo using antisense therapy [59]. A similar induction of
HSP47 expression, along with the excessive accumulation
of collagens, is also noted in experimental models of
diabetic nephropathy and hypertensive nephrosclerosis [16,
36]. Increased expression of HSP47 is always detected in
collagen-producing interstitial myofibroblasts and tubular
epithelial cells in various experimental models of renal
tubulointerstitial fibrosis, such as age-associated nephrop-
athy in F-344 rats and in radiation-induced tubulointerstitial
nephritis [17, 47, 48].
Consistent with renal fibrotic diseases, increased ex-
pression of HSP47 and collagen accumulation are also
detected in bleomycin-induced experimental pulmonary
fibrosis [39]. As observed in the experimental fibrotic
diseases, the expression of HSP47 correlates with the degree
of collagen accumulation in various human fibrotic dis-
eases [4, 14, 37, 38, 44, 46, 71]. For instance, increased
expression of HSP47 in glomeruli and the tubulointerstitium
correlates with glomerular and tubulointerstitial accumula-
tion of type IV collagen and type III collagen, respectively,
in human IgA nephropathy and diabetic nephropathy [44].
A similar correlation is also noted in human pulmonary
fibrotic diseases [46]. Furthermore, a profibrogenic role of
HSP47 has been proposed in the development of fibrotic
lesions in the liver and heart [4, 62]. Fatty changes and
extensive fibrosis are both severe complications observed in
patients with chronic alcoholism (also referred as alcoholic
liver cirrhosis) (Fig. 1). Increased expression of HSP47 is
associated with the increased accumulation of collagen in
alcoholic liver cirrhosis (Fig. 2). These HSP47-expressing
cells in alcoholic liver cirrhosis are primarily fibroblasts
and myofibroblasts. Similarly, in patients with keloids
[25] and cicatricial pemphigoid [34], increased dermal
expression of HSP47 is correlated with the accumulation
of interstitial collagens around areas of dermal fibrosis; a
similar correlation is also found in human conjunctival scar-
ring diseases in patients with ocular cicatricial pemphigoid
[35, 37, 38]. Hereditary gingival fibromatosis is usually
characterized by increased accumulation of collagen in the
gingival tissue of the affected patients; fibroblasts isolated
from normal and fibrotic gingival tissues showed relative-
ly increased expression of HSP47 with significantly higher
Fig. 2. Compared to the control liver, an increased expression of HSP47 is noted in alcoholic liver cirrhosis, as detected by immunohistochemis-
try (upper panel, arrows). Increased expression of HSP47 is associated with the increased accumulation of collagens (detected by Azan-Mallory
stain, lower panel, arrows) in the fibrotic areas of alcoholic liver cirrhosis.Taguchi et al. 38
Fig. 3. Histological features of lung of a normal rat (A), showing no significant histological changes, while in a bleomycin-treated rat, there is
marked fibrosis in the lung (B). Immunohistochemistry for HSP47 in a control lung, showing weak staining for HSP47, mainly located in the
interstitial cells (C). In contrast, markedly increased HSP47 expression is noted, mainly in the stromal interstitial cells, in bleomycin-treated rat
lungs (D). Weak immunostaining of type III collagens is noted in the control lungs (E). Increased accumulation of type III collagen is noted in
the fibrotic areas of a bleomycin-treated lung (F). Please note that bleomycin-induced pulmonary fibrosis (B) is associated with increased
expression of HSP47 (D) and excessive accumulation of collagens (F) in the fibrotic mass. (Reproduced from reference 39 with the permission
from Springer publisher).
Fig. 4. Immunohistochemistry for α-smooth muscle actin in the control rat lung and is showing mostly in the vessel wall expression (A).
Compared with the control lung, markedly increased expression for α-smooth muscle actin is noted in the bleomycin-treated rat lung (B).
Immunohistochemistry for vimentin, showing weak immunostaining in the control rat lung (D), while, an increased number of vimentin-
positive cells are noted in the bleomycin-treated rat lung (E). Please note that double staining shows that both α-smooth muscle actin-positive
cells (C, red staining), and vimentin-positive cells (F, red staining) are also HSP47 expressing cells (black). (Reproduced from reference 39
with the permission from Springer publisher).HSP47 and Fibrosis 39
collagen production by the fibroblasts isolated from the
patient with hereditary gingival fibromatosis [19]. An
association between HSP47 expression and excessive dep-
osition of collagen is also noted in patients with oral sub-
mucosal fibrosis [11]. In summary, findings from human
and experimental fibrotic diseases clearly suggest that
upregulation of HSP47 is a common phenomenon during
collagenization of the involved organ, regardless of the
primary disease.
Fibrogenic factors such as transforming growth factor
(TGF)-β1 are produced by the activated and phenotypically
altered resident cells and infiltrating inflammatory cells, and
these have the potential to mediate both human and experi-
mental fibrotic diseases by contributing to the increased
production of collagens and thus matrix remodeling [34, 37,
61, 63]. TGF-β1 affects matrix remodeling by stimulating
the transcription of genes encoding collagen proteins,
while HSP47 plays an important role in fibrosis by post-
transcriptional upregulation of collagens [16, 23, 48, 61,
63, 67]. Importantly, TGF-β1 can induce the expression of
HSP47 [37, 70].
IV. HSP47 Is a Marker of Collagen-Producing 
Cells in Fibrotic Diseases
Organogenesis and fibrogenesis are complex process
[10, 54, 56, 66]. During fibrosis, in addition to proliferation
of fibroblasts, resident cells usually undergo phenotypic
changes to produce excessive amounts of collagen, thus pro-
moting fibrogenesis. To date, there is no universal histologic
marker for collagen-producing cells to identify these cells in
histological sections. For instance, during renal fibrosis,
glomerular mesangial cells, tubular epithelial cells and inter-
stitial cells change their phenotypes to produce increased
amounts of collagen. The expression of alpha-smooth
muscle actin by mesangial and interstitial cells is commonly
used as a marker for phenotypic alteration in these cells,
which produce increased amounts of collagen that induce
glomerulosclerosis and interstitial fibrosis [24]. Similarly,
the phenotypic transformation of renal tubular epithelial
cells, which generate increased amounts of collagen leading
to renal tubulointerstitial fibrosis [7], can be identified
using mesenchymal markers like vimentin. Interestingly, all
of the phenotypically altered glomerular mesangial cells,
tubular epithelial cells and interstitial cells express HSP47,
a common marker of collagen synthesis [5, 16, 17, 44, 47,
48, 50–52]. Likewise, increased numbers of alpha-smooth
muscle actin-positive myofibroblasts and vimentin-positive
fibroblasts are the main collagen-producing cells in both
human and experimental fibrotic lung tissues [69, 74, 75].
Again, in both human and experimental pulmonary fibrotic
diseases with increased accumulation of collagens (Fig. 3),
these phenotypically altered cells, which are identified by
different histological markers, are also HSP47-expressing
cells [39, 46] (Fig. 4), suggesting the potential of HSP47
as a universal marker to identify phenotypically altered
collagen-producing cells. It is worth mentioning that the
expression of HSP47 in collagen-producing cells during
fibrosis is a collective phenomenon, irrespective of organ
involvement [34, 37, 43, 44, 46, 60]. As mentioned, co-
localization studies suggest that phenotypically altered
collagen-producing cells are always HSP47-expressing cells.
Such observations lead us to propose that HSP47 is a novel
biomarker of phenotypically altered collagen-producing
cells during wound healing and fibrosis.
V. Conclusion
The synthesis and post-translational modification of
collagen require the help of numerous enzymes and chaper-
ones to generate a stable collagen protein in the correct
conformation [2]. HSP47 is present in the endoplasmic
reticulum of collagen-producing cells and helps in the
correct formation of the collagen quaternary structure [22].
The expression of HSP47 positively correlates with the
degree of collagen accumulation in human and experimen-
tal fibroproliferative diseases [5, 20, 37, 39, 44, 46, 47,
52]. Since HSP47 has a single substrate protein, collagen,
the de novo expression of HSP47 acts as a novel histologi-
cal biomarker to identify phenotypically altered collagen-
producing cells during fibrosis and other relevant disorders.
The commercial availability of HSP47 antibody and its
sensitivity and reactivity on routine paraffin sections are
additional advantage for the user. The specific identification
of collagen-producing cells based on HSP47 expression
will help in designing cell-based therapies to slow the
progression of fibrotic diseases. Finally, given that HSP47
is involved in nearly all stages of the fibrotic process by
facilitating the increased production of collagen, HSP47
presents a unique therapeutic target for selective inactivation
with the goal of either preventing or delaying the progres-
sion of fibrotic diseases.
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